These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 31606546)

  • 21. Outcomes and prognosticators in regionally recurrent cutaneous squamous cell carcinoma of the head and neck.
    Wilkie MD; Chudek DA; Flynn CD; Gaskell P; Loh C; Tandon S; Roland NJ; Jones TM; Lancaster J
    Eur J Surg Oncol; 2020 Nov; 46(11):2035-2041. PubMed ID: 32800595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parotid and cervical nodal status predict prognosis for patients with head and neck metastatic cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Allison RS; Chaplin JM; Gregor RT; Lea R; Tan ST
    J Surg Oncol; 2008 Aug; 98(2):101-5. PubMed ID: 18523982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of primary and adjuvant radiotherapy for cutaneous squamous cell carcinomas of the head-and-neck region in the elderly.
    Haehl E; Rühle A; Klink R; Kalckreuth T; Sprave T; Gkika E; Zamboglou C; Meiß F; Grosu AL; Nicolay NH
    Radiat Oncol; 2021 Jun; 16(1):105. PubMed ID: 34118984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgery and adjuvant radiotherapy in patients with cutaneous head and neck squamous cell carcinoma metastatic to lymph nodes: combined treatment should be considered best practice.
    Veness MJ; Morgan GJ; Palme CE; Gebski V
    Laryngoscope; 2005 May; 115(5):870-5. PubMed ID: 15867656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lymph-node-positive cutaneous nonmelanoma skin cancer: A poor-prognosis disease in need of treatment intensification.
    Wang LS; Handorf EA; Ridge JA; Burtness BA; Lango MN; Mehra R; Liu JC; Galloway TJ
    Ear Nose Throat J; 2017 Jul; 96(7):E12-E18. PubMed ID: 28719713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lymph node ratio as a prognostic factor in head and neck cancer patients.
    Chen CC; Lin JC; Chen KW
    Radiat Oncol; 2015 Aug; 10():181. PubMed ID: 26302761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
    Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
    Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma.
    Haque S; Karivedu V; Riaz MK; Choi D; Roof L; Hassan SZ; Zhu Z; Jandarov R; Takiar V; Tang A; Wise-Draper T
    Oral Oncol; 2019 Jan; 88():9-15. PubMed ID: 30616803
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Classification of Lymph Node Metastases Subtypes Predict for Survival in Head and Neck Cancer.
    Huang L; David O; Cabay RJ; Valyi-Nagy K; Macias V; Zhong R; Wenig B; Feldman L; Weichselbaum R; Spiotto MT
    Clin Cancer Res; 2019 Mar; 25(6):1795-1808. PubMed ID: 30573692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.
    Gootee J; Patel M; Aurit S; Silberstein P
    Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Surgically Treated Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck: Outcome Predictors and the Role of Adjuvant Radiation Therapy.
    Kampel L; Dorman A; Horowitz G; Fliss DM; Gutfeld O; Muhanna N
    Ann Otol Rhinol Laryngol; 2021 Sep; 130(9):1016-1023. PubMed ID: 33514267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Head and neck cutaneous squamous cell carcinoma requiring parotidectomy: prognostic indicators and treatment selection.
    Sweeny L; Zimmerman T; Carroll WR; Schmalbach CE; Day KE; Rosenthal EL
    Otolaryngol Head Neck Surg; 2014 Apr; 150(4):610-7. PubMed ID: 24474713
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Head and neck squamous cell carcinoma of unknown primary: Outcomes of a pre-defined institutional treatment policy in a region with a high prevalence of skin cancer.
    Huo M; Panizza B; Bernard A; Porceddu SV
    Oral Oncol; 2018 Feb; 77():43-48. PubMed ID: 29362125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
    Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
    JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk and Survival of Patients with Head and Neck Cutaneous Melanoma: National Perspective.
    Al-Qurayshi Z; Hassan M; Srivastav S; Sperry S; Pagedar N; Hamner J; Kandil E
    Oncology; 2017; 93(1):18-28. PubMed ID: 28423377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes.
    Hinerman RW; Indelicato DJ; Amdur RJ; Morris CG; Werning JW; Vaysberg M; Kirwan J; Mendenhall WM
    Laryngoscope; 2008 Nov; 118(11):1989-96. PubMed ID: 18849863
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial.
    Noronha V; Joshi A; Patil VM; Agarwal J; Ghosh-Laskar S; Budrukkar A; Murthy V; Gupta T; D'Cruz AK; Banavali S; Pai PS; Chaturvedi P; Chaukar D; Pande N; Chandrasekharan A; Talreja V; Vallathol DH; Mathrudev V; Manjrekar A; Maske K; Bhelekar AS; Nawale K; Kannan S; Gota V; Bhattacharjee A; Kane S; Juvekar SL; Prabhash K
    J Clin Oncol; 2018 Apr; 36(11):1064-1072. PubMed ID: 29220295
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insurance Status is Associated With Recurrence in Cutaneous Head and Neck Squamous Cell Carcinoma.
    Victor MT; Zheng W; Park SJ; Jiang SIB; Guo TW
    Otolaryngol Head Neck Surg; 2024 Jan; 170(1):132-140. PubMed ID: 37622529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical perineural invasion of the trigeminal and facial nerves in cutaneous head and neck squamous cell carcinoma: Outcomes and prognostic implications of multimodality and salvage treatment.
    Erkan S; Savundra JM; Wood B; Acharya AN; Rajan GP
    Head Neck; 2017 Jul; 39(7):1280-1286. PubMed ID: 28474414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.